University of Minnesota
https://twin-cities.umn.edu/
612-625-5000
Milestone
5.2.b

Virus strain availability

In progress
High priority

Ensure the broad availability to investigators of a biorepository of diverse, well-characterized challenge viruses, cell lines, and human samples for manufacture and CHIVIM studies.

Progress Highlights

NIAID is in the process of making challenge strains available for H3N2 and H1N1.


NIAID released the Notice to “Inform the Extramural Influenza Research Community of the Availability of Materials for Controlled Human Influenza Virus Infection Model (CHIVIM) Clinical Studies and Trials (Sep 15, 2023). 

See notice